rs61739385

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_020461.4(TUBGCP6):​c.3307C>T​(p.Arg1103Trp) variant causes a missense change. The variant allele was found at a frequency of 0.00149 in 1,612,410 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1103Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0078 ( 15 hom., cov: 34)
Exomes 𝑓: 0.00084 ( 14 hom. )

Consequence

TUBGCP6
NM_020461.4 missense

Scores

1
7
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.24

Publications

5 publications found
Variant links:
Genes affected
TUBGCP6 (HGNC:18127): (tubulin gamma complex component 6) The protein encoded by this gene is part of a large multisubunit complex required for microtubule nucleation at the centrosome. [provided by RefSeq, Jul 2008]
TUBGCP6 Gene-Disease associations (from GenCC):
  • microcephaly and chorioretinopathy 1
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0074418485).
BP6
Variant 22-50221052-G-A is Benign according to our data. Variant chr22-50221052-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 445785.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00777 (1177/151468) while in subpopulation AFR AF = 0.0272 (1119/41122). AF 95% confidence interval is 0.0259. There are 15 homozygotes in GnomAd4. There are 571 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TUBGCP6NM_020461.4 linkc.3307C>T p.Arg1103Trp missense_variant Exon 16 of 25 ENST00000248846.10 NP_065194.3
TUBGCP6XR_001755343.3 linkn.3871C>T non_coding_transcript_exon_variant Exon 16 of 20
TUBGCP6XR_938347.3 linkn.3871C>T non_coding_transcript_exon_variant Exon 16 of 23
TUBGCP6XR_007067982.1 linkn.3048+976C>T intron_variant Intron 15 of 18

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TUBGCP6ENST00000248846.10 linkc.3307C>T p.Arg1103Trp missense_variant Exon 16 of 25 1 NM_020461.4 ENSP00000248846.5
TUBGCP6ENST00000439308.7 linkn.3307C>T non_coding_transcript_exon_variant Exon 16 of 25 1 ENSP00000397387.2
TUBGCP6ENST00000498611.5 linkn.3617+223C>T intron_variant Intron 16 of 22 1
TUBGCP6ENST00000491449.5 linkn.1614C>T non_coding_transcript_exon_variant Exon 8 of 16 5

Frequencies

GnomAD3 genomes
AF:
0.00776
AC:
1175
AN:
151352
Hom.:
15
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0272
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00237
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00626
GnomAD2 exomes
AF:
0.00191
AC:
481
AN:
251452
AF XY:
0.00129
show subpopulations
Gnomad AFR exome
AF:
0.0261
Gnomad AMR exome
AF:
0.00116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000527
Gnomad OTH exome
AF:
0.00114
GnomAD4 exome
AF:
0.000840
AC:
1227
AN:
1460942
Hom.:
14
Cov.:
37
AF XY:
0.000722
AC XY:
525
AN XY:
726806
show subpopulations
African (AFR)
AF:
0.0286
AC:
956
AN:
33406
American (AMR)
AF:
0.00144
AC:
64
AN:
44434
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26104
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39636
South Asian (SAS)
AF:
0.000139
AC:
12
AN:
86138
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53370
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000675
AC:
75
AN:
1111744
Other (OTH)
AF:
0.00184
AC:
111
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
98
196
293
391
489
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00777
AC:
1177
AN:
151468
Hom.:
15
Cov.:
34
AF XY:
0.00771
AC XY:
571
AN XY:
74020
show subpopulations
African (AFR)
AF:
0.0272
AC:
1119
AN:
41122
American (AMR)
AF:
0.00236
AC:
36
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5110
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10488
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000103
AC:
7
AN:
67930
Other (OTH)
AF:
0.00619
AC:
13
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
50
100
150
200
250
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00218
Hom.:
3
Bravo
AF:
0.00886
ESP6500AA
AF:
0.0238
AC:
105
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.00248
AC:
301
EpiCase
AF:
0.000327
EpiControl
AF:
0.000237

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 19, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.44
CADD
Uncertain
24
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.19
T;.
Eigen
Uncertain
0.41
Eigen_PC
Uncertain
0.31
LIST_S2
Uncertain
0.93
D;D
MetaRNN
Benign
0.0074
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.6
M;.
PhyloP100
4.2
PrimateAI
Benign
0.30
T
PROVEAN
Uncertain
-3.7
D;D
Sift
Uncertain
0.0070
D;D
Sift4G
Uncertain
0.0040
D;D
Vest4
0.50
ClinPred
0.036
T
GERP RS
4.9
Varity_R
0.14
gMVP
0.40
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61739385; hg19: chr22-50659481; COSMIC: COSV99030488; COSMIC: COSV99030488; API